You can buy it. But don't buy blindly, be skillful. At present, the retreat of China-Europe medical care is indeed great. If I hadn't entered the market before, I might choose to open positions in batches. If my previous position is already high, I will choose to continue to make a fixed investment and control my position appropriately.

In the whole medical sector, CEIBS Medical is a fund with better performance. Let's take a look at the performance of Central Europe in recent years. China and Europe ranked third in similar products in the past year, 12 in the last three years and seventh in the last five years. If we only look at the historical income, CEIBS Medical is indeed a good fund product and worth holding.

Because China-Europe Medical has a certain recovery rate at present, this is a good opportunity to get on the bus. Instead of optimistic about China-Europe medical care, it is better to be optimistic about the entire medical sector. I am very optimistic about the medical sector, and I also believe that the medical sector will get out of the slow bull market in the long-term market. It is also for this reason that many people are also holding relevant products of China Europe Medical. No matter how the market fluctuates, don't choose to take profit easily. Because if you take profit or stop loss now, the cost of the next entry may be higher. Because everyone has their own investment background, you should make independent decisions according to your own investment background. If you already have a certain position before, you can selectively add positions under the premise of position control. If you haven't entered the market before, you can really choose to buy at this time.

The difference between medical care A and C in China and Europe;

1. From the name, they belong to Class A funds and Class C funds respectively;

The main difference is the speed:

2. Subscription fee:

China-Europe medical and health mixture a:

If it is less than 1 10,000 yuan, a handling fee of 0. 15% will be charged;

If it is greater than or equal to 1 10,000 yuan and less than 5 million yuan, a handling fee of 0.08% will be charged;

If it is more than or equal to 5 million yuan, each handling fee is 1000 yuan.

China-Europe medical and health mixture c:

There is no handling fee.

3. Management fee:

China-Europe medical and health mixture a:

The management fee is 1.50% (per year);

The escrow rate is 0.25% (per year);

The sales service rate is 0.00% (per year).

China-Europe medical and health mixture c:

The management fee is 1.50% (per year);

The escrow rate is 0.25% (per year);

The sales service rate is 0.80% (per year).

So the main difference between them is that C has no subscription fee, A has subscription fee, but A has no sales service fee, and C has sales service fee.